Emerging Microbes and Infections (Jan 2021)

Blood virosphere in febrile Tanzanian children

  • Samuel Cordey,
  • Florian Laubscher,
  • Mary-Anne Hartley,
  • Thomas Junier,
  • Kristina Keitel,
  • Mylène Docquier,
  • Nicolas Guex,
  • Christian Iseli,
  • Gael Vieille,
  • Philippe Le Mercier,
  • Anne Gleizes,
  • Josephine Samaka,
  • Tarsis Mlaganile,
  • Frank Kagoro,
  • John Masimba,
  • Zamzam Said,
  • Hosiana Temba,
  • Gasser H. Elbanna,
  • Caroline Tapparel,
  • Marie-Celine Zanella,
  • Ioannis Xenarios,
  • Jacques Fellay,
  • Valérie D’Acremont,
  • Laurent Kaiser

DOI
https://doi.org/10.1080/22221751.2021.1925161
Journal volume & issue
Vol. 10, no. 1
pp. 982 – 993

Abstract

Read online

Viral infections are the leading cause of childhood acute febrile illnesses motivating consultation in sub-Saharan Africa. The majority of causal viruses are never identified in low-resource clinical settings as such testing is either not part of routine screening or available diagnostic tools have limited ability to detect new/unexpected viral variants. An in-depth exploration of the blood virome is therefore necessary to clarify the potential viral origin of fever in children. Metagenomic next-generation sequencing is a powerful tool for such broad investigations, allowing the detection of RNA and DNA viral genomes. Here, we describe the blood virome of 816 febrile children (<5 years) presenting at outpatient departments in Dar es Salaam over one-year. We show that half of the patients (394/816) had at least one detected virus recognized as causes of human infection/disease (13.8% enteroviruses (enterovirus A, B, C, and rhinovirus A and C), 12% rotaviruses, 11% human herpesvirus type 6). Additionally, we report the detection of a large number of viruses (related to arthropod, vertebrate or mammalian viral species) not yet known to cause human infection/disease, highlighting those who should be on the radar, deserve specific attention in the febrile paediatric population and, more broadly, for surveillance of emerging pathogens.Trial registration: ClinicalTrials.gov identifier: NCT02225769.

Keywords